U.S. Markets open in 2 hrs 20 mins

Portola Pharmaceuticals posts 4Q loss

SOUTH SAN FRANCISCO, Calif. (AP) _ Portola Pharmaceuticals Inc. (PTLA) on Tuesday reported a loss of $53.8 million in its fourth quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 95 cents.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.10 per share.

The biopharmaceutical company posted revenue of $13.7 million in the period.

For the year, the company reported that its loss widened to $269 million, or $4.76 per share. Revenue was reported as $35.5 million.

Portola Pharmaceuticals shares have risen 55 percent since the beginning of the year. The stock has climbed 23 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTLA at https://www.zacks.com/ap/PTLA

_____

Keywords: Portola Pharmaceuticals, Earnings Report